# Clinical Genetics * **Definition:** A clinical service that offers genetic testing and counseling to assess and manage genetic disorders. * **Taxonomy:** Specialties / Clinical Genetics ## News * Selected news on the topic of **Clinical Genetics**, for healthcare technology leaders * 3.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/19/2025 | [**STAT+: Regeneron to buy 23andMe out of bankruptcy for $256 million**](https://www.statnews.com/2025/05/19/23andme-regeneron-bankruptcy-genetic-testing-patient-data/?utm_campaign=rss) | [[STAT]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/17/2024 | [**Press Registration Is Now Open for the 2025 ACMG Annual Clinical Genetics Meeting**](https://www.prnewswire.com/news-releases/press-registration-is-now-open-for-the-2025-acmg-annual-clinical-genetics-meeting-302332901.html) | [[PR Newswire]] | | 12/7/2024 | [**Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27AGR - Report by S&S Insider**](https://finance.yahoo.com/news/genotyping-market-hit-usd-59-140000786.html) | [[Yahoo Finance]] | | 11/26/2024 | [**Mount Sinai leans into AI with new research center - Healthcare Finance News**](https://www.healthcarefinancenews.com/news/mount-sinai-leans-ai-new-research-center) | [[Healthcare Finance]] | | 11/26/2024 | [**Mount Sinai Center to Combine AI, Data Science, Genomics - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/55246083/mount-sinai-center-to-combine-ai-data-science-genomics) | [[Healthcare Innovation]] | | 11/25/2024 | [**Mount Sinai Health announces new Center for AI and Human Health - Healthcare IT News**](https://www.healthcareitnews.com/news/mount-sinai-health-announces-new-center-ai-and-human-health) | [[Healthcare IT News]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/8/2024 | [**AI-driven precision healthcare is here - what you need to know**](https://www.healthcareitnews.com/news/ai-driven-precision-healthcare-here-what-you-need-know) | [[Healthcare IT News]] | | 11/7/2024 | [**Next-Generation Sequencing (NGS) Services Market is expected to generate a revenue of ...**](https://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-services-market-is-expected-to-generate-a-revenue-of-usd-18-35-billion-by-2031--globally-at-21-25-cagr-verified-market-research-302298672.html) | [[PR Newswire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.morningstar.com/news/business-wire/20241008712158/seqster-ceo-ardy-arianpour-named-to-pharmavoice-100-for-innovation-in-life-sciences-for-a-second-consecutive-year) | [[Morningstar]] | | 10/7/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](https://www.businesswire.com/news/home/20241008712158/en/) | [[Business Wire]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/10/2024 | [**LH Stock Expected to Gain From the Ballad Health Acquisition Deal**](https://finance.yahoo.com/news/lh-stock-expected-gain-ballad-122400434.html) | [[Yahoo Finance]] | | 7/22/2024 | [**Robert T. Braithwaite, Channing Hamlet and Daniel A. Platt Share Insights on ... - Los Angeles Times**](https://www.latimes.com/business-insights/story/2024-07-22/robert-t-braithwaite-channing-hamlet-and-daniel-a-platt-share-insights-on-the-healthcare-biotech-and-life-sciences-landscape-in-2024) | [[LA Times]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Clinical Geneticists**: Medical doctors specializing in diagnosing and managing genetic disorders. - **Genetic Counselors**: Healthcare professionals who provide information and support to individuals and families regarding genetic conditions and testing. - **Genomics Companies**: Organizations that focus on genetic testing and analysis, often utilizing advanced technologies to provide insights into genetic conditions. - **Genome Medical**: Enhances the identification of clinical trial patients for ultra-rare diseases using clinical-grade data. - **Myriad Genetics**: Another key player in the genetic testing market, focusing on personalized healthcare solutions. - **Labcorp**: A global leader in laboratory services, enhancing genetic testing solutions through acquisitions. - **Genomics plc**: A genomics company that focuses on leveraging genetic data for healthcare advancements, including drug discovery and patient care. - **GeneDx**: A provider of genetic testing services that has launched a data visualization tool to enhance drug development. - **Foundation Medicine**: A leader in precision medicine, focusing on genomic profiling to inform cancer treatment decisions. - **MyOme, Inc.**: A company specializing in genetics-driven clinical risk assessments and whole genome sequencing. - **Genoks**: A Turkish genomics healthcare company focused on cancer diagnostics and treatment. - **LetsGetChecked**: A healthcare company expanding its genomic testing and personalized healthcare solutions. - **23andMe**: A major player in the direct-to-consumer genetic testing market, offering predictive tests for various diseases. - **Galatea Bio**: A company focused on enhancing access to advanced genetic tools and services, particularly for underserved populations. - **Ambry Genetics**: A leader in genetic testing, recently acquired by Tempus AI to enhance testing capabilities. - **Foundation Medicine, Inc.**: A significant contributor to precision medicine software, focusing on genomic data analysis and personalized treatment options. ### Partnerships and Collaborations - **Biotechnology Firms and Clinical Labs**: Partnerships aimed at developing new genetic tests and therapies, enhancing the capabilities of clinical genetics. - **PatientsLikeMe and Genome Medical**: Partnering to provide genetics-driven healthcare solutions, enhancing patient self-management through genetic counseling. - **MyOme and Broad Clinical Labs**: Partnering to provide genetics-driven clinical risk assessments in Alabama. - **GeneDx and biopharmaceutical companies**: Collaborating to improve patient access to genetic testing and expedite treatment development for rare diseases. - **Myriad Genetics and Flatiron Health**: Integrating MyRisk Hereditary Cancer Test into OncoEMR to improve access to genetic testing. - **Academic Institutions and Healthcare Providers**: Collaborations between universities and hospitals to advance research in genetic disorders and improve patient care. - **Epic and GeneDx**: Collaborating to integrate rapid whole genome sequencing technology into Epic's EHR system for improved genomic insights. - **Labcorp and Ultima Genomics**: Collaboration to utilize UG 100 sequencing technology for new clinical applications in whole genome sequencing. - **Genoks and Velsera**: Collaborating to integrate advanced genomic analysis technologies for cancer diagnostics. - **Labcorp and Invitae**: Acquisition to enhance genetic testing solutions for oncology and rare diseases. - **MyOme, Inc. and Broad Clinical Labs**: Partnering to support the Catalyst program aimed at providing genetics-driven clinical risk assessments. - **Children's National Hospital and Virginia Tech**: Collaborating to develop precision medicine based on pediatric genomic research. - **Tempus AI and Ambry Genetics**: Acquisition aimed at enhancing genetic testing capabilities and expanding disease coverage. - **Principle Health Systems and Telos PGX**: Acquisition aimed at enhancing personalized medication solutions through advanced pharmacogenetic testing. - **DNAnexus and Galatea Bio**: Strategic collaboration to enhance biomedical research for underserved populations. - **Velsera and Diagnostic Longwood**: A partnership to enhance NGS solutions in the Iberian market, integrating Velsera's Clinical Genomics Workspace with local distribution networks. - **Texas A&M Health and BurstIQ**: A partnership to utilize BurstIQ's LifeGraph platform for genomic data governance, enhancing collaborative genomics research. - **Mount Sinai and Hasso Plattner Institute**: Collaboration to enhance capabilities in data science and AI, focusing on genomic health and personalized medicine. ### Innovations, Trends, and Initiatives - **Clinical Genomics Workspace**: A platform designed to support oncology and inherited disease specialists. - **Telehealth in Genetic Counseling**: The use of telemedicine to provide genetic counseling services, increasing access for patients in remote areas. - **Whole Genome and Exome Sequencing**: Increasingly integrated into clinical practice, significantly impacting diagnostics and therapeutic interventions. - **Precision Medicine**: Utilizes genetic, environmental, and lifestyle factors to tailor treatments, with a focus on improving patient outcomes. - **Hyper-Personalized Medicine**: An approach tailoring treatments based on genetic makeup, environment, and lifestyle, driven by advancements in genomics. - **English National Lynch Syndrome Registry**: A database linking cancer diagnosis and treatment data with genomic information to enhance prevention strategies. - **GeneDx Discover**: A novel data visualization tool that provides biopharmaceutical companies with access to deidentified genetic data. - **Integration of AI in Genetic Analysis**: Artificial intelligence tools are being developed to analyze genetic data, aiding in the identification of genetic disorders. - **Genetic Testing Innovations**: Recent developments in genetic testing are raising concerns about privacy and security of personal health data. - **Direct-to-Consumer Genetic Testing Growth**: Significant growth driven by advancements in next-generation sequencing technologies and consumer interest. - **AI-Driven Genomic Analysis**: Utilization of AI to analyze genomic data for personalized healthcare solutions, enhancing patient outcomes. - **Emirati Genome Programme**: Integrating genomic data into healthcare decision-making for precision medicine. - **Next-Generation Sequencing (NGS)**: Advancements in NGS technologies are driving growth in the direct-to-consumer genetic testing market. - **Whole-Exome Sequencing (WES)**: Increasingly used in clinical diagnostics to identify genetic factors affecting diseases, driven by advancements in AI and bioinformatics. - **CRISPR and Wearable Technology**: Enhancing personalization in healthcare through continuous monitoring and potential gene editing. - **VarSome Clinical Platform**: Automates the discovery and interpretation of NGS data, receiving CE mark approval. - **AI and Machine Learning**: Transforming precision medicine by enabling early disease classification and personalized treatment pathways. ### Challenges and Concerns - **Access to Genetic Testing**: Disparities in access to genetic testing and counseling services, particularly in underserved populations. - **Privacy Concerns**: Issues surrounding data security and privacy in genetic testing and healthcare. - **Ethical Implications**: The ethical considerations surrounding genetic testing, including potential discrimination based on genetic information. - **Training Needs**: Extensive training required for healthcare professionals to effectively utilize new genetic testing technologies. - **Health Risks**: Potential health risks associated with genetic testing and the complexities of interpreting genetic disorders. - **Data Privacy and Security**: Concerns regarding patient privacy and informed consent in genetic testing and data sharing. - **Data Privacy**: Concerns regarding the security and potential re-identification of de-identified data, especially in light of recent changes in genetic testing laws. - **Regulatory Frameworks**: Need for robust regulations to ensure safety and effectiveness in genetic testing. - **High Costs of Precision Medicine**: Challenges in affordability and accessibility of personalized treatments. - **Ethical and Regulatory Challenges**: Navigating ethical concerns and regulatory frameworks as AI-powered precision medicine becomes more prevalent. - **Implementation Costs**: High costs and interoperability issues hinder the widespread adoption of precision medicine technologies. - **Data Fragmentation**: Hinders advancements in patient care and clinical research, obstructing personalized treatment interventions. - **FDA Regulations on LDTs**: Concerns about new FDA rules potentially hindering diagnostic innovation. - **Funding Gaps in Pediatric Research**: A notable funding gap in pediatric research compared to adult healthcare advancements. - **Patient Consent**: Many patients are unaware of whether they have consented to the use of their data, highlighting the need for clearer communication and understanding of HIPAA regulations. - **Integration of AI**: Issues related to data quality, interpretability of AI models, and the need for specialized skills in the workforce. ## Related Topics [[Clinical Genomics]]; [[Medical Genetics]]; [[Laboratory Genetics]]; [[Clinical Biochemical Genetics]]; [[Genetic Pathology]]; [[Clinical Cytogenetics]]; [[Genetic Testing]]; [[Biochemical Genetics]]; [[Medical Biochemical Genetics]]